{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05575037",
            "orgStudyIdInfo": {
                "id": "2022P002407"
            },
            "secondaryIdInfos": [
                {
                    "id": "U19AI095219",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U19AI095219"
                }
            ],
            "organization": {
                "fullName": "Brigham and Women's Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease",
            "officialTitle": "Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease: MARINER",
            "acronym": "MARINER",
            "therapeuticArea": [
                "Respiratory",
                "Other"
            ],
            "study": "mechanisms-of-benefit-of-inhibition-in-aspirin-exacerbated-respiratory-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-04-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-10-07",
            "studyFirstSubmitQcDate": "2022-10-07",
            "studyFirstPostDateStruct": {
                "date": "2022-10-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-27",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Tanya Laidlaw, MD",
                "investigatorTitle": "Associate Professor of Medicine",
                "investigatorAffiliation": "Brigham and Women's Hospital"
            },
            "leadSponsor": {
                "name": "Brigham and Women's Hospital",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Allergy and Infectious Diseases (NIAID)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The overall aim of the study is to determine the clinical efficacy and mechanisms of action of anti-IL-4a (dupilumab) as treatment for patients with Aspirin-Exacerbated Respiratory Disease (AERD).",
            "detailedDescription": "The protocol involves an 8-week trial of dupilumab in patients with AERD. Participants will have 4 total doses of dupilumab administered, with each dose administered every 2 weeks. There will be full clinical assessments and biospecimen collections at Baseline (Visit 1), Week 2 (Visit 2), and Week 8 (Visit 3)."
        },
        "conditionsModule": {
            "conditions": [
                "Nasal Polyps",
                "Asthma, Aspirin-Induced",
                "Aspirin-Exacerbated Respiratory Disease",
                "Aspirin-Sensitive Asthma With Nasal Polyps"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 33,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dupilumab",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will receive dupilumab (300mg every-other-week for 8 weeks).",
                    "interventionNames": [
                        "Drug: Dupilumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Dupilumab",
                    "description": "8-week trial of dupilumab (an anti-IL-4a) in patients with AERD.",
                    "armGroupLabels": [
                        "Dupilumab"
                    ],
                    "otherNames": [
                        "Dupilumab Prefilled Syringe [Dupixent]"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Nasal fluid levels of LTE4",
                    "description": "The nasal fluid levels of LTE4 will be measured at week 8 and will serve as a surrogate biomarker of respiratory mast cell activation or burden.",
                    "timeFrame": "At Week 8 (Visit 3)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Nasal fluid levels of albumin",
                    "description": "The nasal fluid levels of albumin will be measured at week 8 and serve as a surrogate biomarker of nasal epithelial cell integrity.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Sense of smell - University of Pennsylvania Smell Identification Test (UPSIT)",
                    "description": "Patients' sense of smell will be assessed at week 8 using the UPSIT.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Rhinoscopic Total Polyp Score (TPS)",
                    "description": "The extent of patients' nasal polyps will be assessed at week 8 using a TPS.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Peak Nasal Inspiratory Flow (PNIF)",
                    "description": "Patients' nasal congestion will be assessed at week 8 by a PNIF.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Quality of life - 22-Item Sino-Nasal Outcome Test (SNOT-22)",
                    "description": "Quality of life will be assessed at week 8 with a SNOT-22.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Lung function - Forced Expiratory Volume 1 (FEV1)",
                    "description": "Patients' lung function will be assessed at week 8 with an FEV1.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Asthma control - Asthma Control Questionnaire-6 (ACQ-6)",
                    "description": "Asthma control will be measured at week 8 with an ACQ-6.",
                    "timeFrame": "At Week 8 (Visit 3)"
                },
                {
                    "measure": "Number of treatment-related adverse events (AEs) and serious adverse events (SAEs) leading to study drug discontinuation",
                    "description": "Safety will be measured by the number of treatment-related AEs and SAEs leading to dupilumab discontinuation.",
                    "timeFrame": "At Week 8 (Visit 3)"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change in sense of smell - University of Pennsylvania Smell Identification Test (UPSIT)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in UPSIT.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in Rhinoscopic Total Polyp Score (TPS)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in TPS.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in Peak Nasal Inspiratory Flow (PNIF)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in PNIF.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in 22-Item Sino-Nasal Outcome Test (SNOT-22)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in SNOT-22.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in lung function - Forced Expiratory Volume 1 (FEV1)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in FEV1.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in Asthma control - Asthma Control Questionnaire-6 (ACQ-6)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in ACQ-6.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in Nasal fluid levels of eicosanoids",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in nasal fluid eicosanoid levels.",
                    "timeFrame": "weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in Nasal fluid levels of albumin",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in nasal fluid albumin levels.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in urinary levels of eicosanoids",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in urinary eicosanoid levels.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in serum tryptase",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in serum tryptase levels.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in IgE levels",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in nasal fluid and plasma levels of IgE.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                },
                {
                    "measure": "Change in eosinophilic cationic protein (ECP)",
                    "description": "Change from Visit 1 to Visit 2 and from Visit 1 to Visit 3 in nasal fluid levels of ECP.",
                    "timeFrame": "2 weeks (between Visit 1 and Visit 2) and 8 weeks (between Visit 1 and Visit 3)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. History of AERD, defined as meeting the diagnostic triad with:\n\n   1. History of physician-diagnosed asthma and\n   2. History of physician-diagnosed nasal polyposis and\n   3. History of pathognomonic reactions to aspirin or other nonselective COX inhibitors.\n2. Visible nasal polyps bilaterally on otoscope physical exam at the time of screening.\n3. Evidence of sense of smell impairment, with a University of Pennsylvania Smell Identification Test (UPSIT) score of \\<34.\n4. Stable asthma (no glucocorticoid burst for at least 4 weeks prior to Visit 1, and no hospitalizations or ER visits for asthma for at least the prior 3 months).\n5. Consistent (daily) use of an intranasal steroid for at least 4 weeks prior to Screening.\n6. No current smoking (not more than one instance of smoking in the last 3 months).\n7. For females: Practicing FDA-approved methods of birth control for the duration of the study. Female participants of childbearing potential must have a negative pregnancy test upon study entry.\n\nKey Exclusion Criteria:\n\n1. Use of investigational drugs within 12 weeks of Screening.\n2. Use of any biologic agent within 4 months prior to Screening.\n3. Use of systemic (enteral or injected) glucocorticoids within 4 weeks prior to Screening.\n4. History of any sinonasal surgery within 4 months prior to Screening\n5. Current use of zileuton\n6. Current use of high-dose aspirin therapy (no more than 325 mg aspirin per day will be allowed)\n7. Pregnant, nursing, or planning to become pregnant\n\nNote: Other inclusion and exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tanya M Laidlaw, MD",
                    "role": "CONTACT",
                    "phone": "617-525-1034",
                    "email": "tlaidlaw@bwh.harvard.edu"
                },
                {
                    "name": "Tessa Ryan",
                    "role": "CONTACT",
                    "phone": "617-525-3824",
                    "email": "tryan6@bwh.harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Tanya M Laidlaw, MD",
                    "affiliation": "Brigham and Women's Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Brigham and Women's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Laura Bailey, BA",
                            "role": "CONTACT",
                            "phone": "857-307-1166",
                            "email": "lbailey0@bwh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001249",
                    "term": "Asthma"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000012120",
                    "term": "Respiration Disorders"
                },
                {
                    "id": "D000009298",
                    "term": "Nasal Polyps"
                },
                {
                    "id": "D000055963",
                    "term": "Asthma, Aspirin-Induced"
                },
                {
                    "id": "D000011127",
                    "term": "Polyps"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001982",
                    "term": "Bronchial Diseases"
                },
                {
                    "id": "D000008173",
                    "term": "Lung Diseases, Obstructive"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012130",
                    "term": "Respiratory Hypersensitivity"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                },
                {
                    "id": "D000009668",
                    "term": "Nose Diseases"
                },
                {
                    "id": "D000010038",
                    "term": "Otorhinolaryngologic Diseases"
                },
                {
                    "id": "D000004342",
                    "term": "Drug Hypersensitivity"
                },
                {
                    "id": "D000064420",
                    "term": "Drug-Related Side Effects and Adverse Reactions"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4556",
                    "name": "Asthma",
                    "asFound": "Asthma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M14011",
                    "name": "Polyps",
                    "asFound": "Polyps",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "asFound": "Respiratory Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14957",
                    "name": "Respiration Disorders",
                    "asFound": "Respiratory Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12249",
                    "name": "Nasal Polyps",
                    "asFound": "Nasal Polyps",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28406",
                    "name": "Asthma, Aspirin-Induced",
                    "asFound": "Asthma, Aspirin-Induced",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5258",
                    "name": "Bronchial Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11170",
                    "name": "Lung Diseases, Obstructive",
                    "relevance": "LOW"
                },
                {
                    "id": "M14967",
                    "name": "Respiratory Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "M12604",
                    "name": "Nose Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12961",
                    "name": "Otorhinolaryngologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7517",
                    "name": "Drug Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M30303",
                    "name": "Drug-Related Side Effects and Adverse Reactions",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000911",
                    "term": "Antibodies, Monoclonal"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4548",
                    "name": "Aspirin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "asFound": "Maintenance therapy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Antipy",
                    "name": "Antipyretics"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "FiAg",
                    "name": "Fibrinolytic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}